CJC-1295 and Ipamorelin are synthetic peptide compounds administered via subcutaneous injection, often combined into a single therapy
Its positive effects on metabolism were further demonstrated in an animal model of obesity, in which treatment with an alcohol extract of clove reduced the negative impact of a high-fat diet on body weight as well as lipid, glucose, and insulin levels (Jung 2012)
Due to high demand and supply shortages, prices remain elevated, though manufacturers and pharmacies often provide discount programs to lower cash prices
Januvia (sitagliptin), produced by Merck, is a DPP-4 inhibitor
The most common side effects are minor and include temporary warmth or flushing (especially with magnesium infusions), mild discomfort at the IV insertion site, and occasional bruising